Aurelia de Pauw

Corporate Officer/Principal en TETRA BIO-PHARMA INC. .

Health Technology

Consumer Services

Perfil

Aurelia de Pauw is currently the Director at TALLC Corp., Inc. and the Vice President-Clinical Programs & Medical Affairs at Tetra Bio-Pharma, Inc. She graduated from Faculté Universitaire des Sciences Agronomiques de Gembloux with a graduate degree in 2005 and received her doctorate degree from Université de Namur ASBL in the same year.

Cargos activos de Aurelia de Pauw

Empresas	Cargo	Inicio
TETRA BIO-PHARMA INC.	Corporate Officer/Principal	01/10/2018
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Director/Miembro de la Junta	-

Todos los cargos activos de Aurelia de Pauw

Formación de Aurelia de Pauw.

Faculté Universitaire des Sciences Agronomiques de Gembloux	Graduate Degree
Université de Namur ASBL	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Aurelia de Pauw.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TETRA BIO-PHARMA INC.	Health Technology

Empresas privadas	1
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Health Technology